国药控股(01099.HK)获Lazard Asset Management LLC增持116.30万股

Group 1 - Lazard Asset Management LLC increased its stake in China National Pharmaceutical Group (国药控股) by acquiring 1,163,040 shares at an average price of HKD 20.699 per share on February 2, 2026, amounting to approximately HKD 24.0738 million [1][2] - Following this acquisition, Lazard Asset Management LLC's total shareholding rose to 148,386,976 shares, increasing its ownership percentage from 10.97% to 11.06% [1][2]